The objective of this study was to measure the effects on postmenopaus
al women of 2 years of either a low dose or a moderate dose regimen of
hormone replacement upon bone mass and serum cardiovascular risk fact
ors. After 6 months of calcium supplementation, 75 women chose to add
hormone replacement or to remain on calcium. Those choosing hormones w
ere randomised to either 0.3 mg/day equine estrogen and 2.5 mg/day med
roxyprogesterone or 0.625 mg/day equine estrogen, days 1-25, and 5 mg/
day medroxyprogesterone, days 16-25. On calcium only, lumbar spine bon
e mineral content and radius bone mass fell. Serum concentrations of c
holesterol and triglycerides increased while HDL concentration fell. T
he low dose continuous regime reduced whole body bone turnover and pre
vented the age related reductions in bone mass and serum cardiovascula
r risk profile. The moderate dose regimen reduced whole body bone turn
over and increased lumbar spine bone mass. Total serum cholesterol was
unchanged while HDL levels increased, LDL levels fell and triglycerid
e concentration increased.